Were Analysts Bearish Laboratory Corporation of America Holdings (NYSE:LH) This Week?

Laboratory Corporation of America Holdings (NYSE:LH) Logo
Investors sentiment decreased to 0.93 in Q2 2019. Its down 0.13, from 1.06 in 2019Q1. It dropped, as 37 investors sold Laboratory Corporation of America Holdings shares while 224 reduced holdings. 64 funds opened positions while 178 raised stakes. 85.95 million shares or 1.95% less from 87.65 million shares in 2019Q1 were reported.
Svcs Automobile Association reported 137,470 shares or 0.06% of all its holdings. Prelude Capital Management Limited Company reported 630 shares stake. Nomura Asset Mgmt has invested 0.03% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). Invesco has 1.18M shares for 0.05% of their portfolio. Sequoia Financial Advsr Limited Liability Company holds 28,296 shares. Stifel Financial reported 50,755 shares stake. Amundi Pioneer Asset owns 764,169 shares for 0.11% of their portfolio. Brown Advisory holds 0.01% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH) for 25,023 shares. Foster Dykema Cabot & Communications Ma holds 0.06% or 2,349 shares in its portfolio. Retirement Of Alabama owns 81,197 shares or 0.07% of their US portfolio. 700 were accumulated by Paradigm Asset Mgmt Co Ltd Liability. Moreover, Gateway Inv Advisers Limited Liability has 0.01% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 4,287 shares. Fmr reported 1.45M shares. Stephens Ar accumulated 8,111 shares or 0.03% of the stock. State Of New Jersey Common Pension Fund D owns 240,000 shares for 0.15% of their portfolio.

Laboratory Corporation of America Holdings (NYSE:LH) Ratings Coverage

Among 7 analysts covering Laboratory Corp (NYSE:LH), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Laboratory Corp has $22000 highest and $16500 lowest target. $188.86’s average target is 9.61% above currents $172.3 stock price. Laboratory Corp had 14 analyst reports since March 15, 2019 according to SRatingsIntel. The stock has “Overweight” rating by KeyBanc Capital Markets on Thursday, August 8. Citigroup maintained Laboratory Corporation of America Holdings (NYSE:LH) on Wednesday, May 1 with “Neutral” rating. On Friday, March 15 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. The stock of Laboratory Corporation of America Holdings (NYSE:LH) has “Overweight” rating given on Friday, August 23 by Morgan Stanley. Deutsche Bank upgraded Laboratory Corporation of America Holdings (NYSE:LH) rating on Friday, June 21. Deutsche Bank has “Buy” rating and $22000 target. The stock of Laboratory Corporation of America Holdings (NYSE:LH) earned “Buy” rating by Barclays Capital on Monday, March 18. Canaccord Genuity maintained the shares of LH in report on Thursday, May 2 with “Hold” rating. The firm has “Overweight” rating given on Friday, July 26 by Morgan Stanley. On Wednesday, May 1 the stock rating was maintained by UBS with “Buy”. Below is a list of Laboratory Corporation of America Holdings (NYSE:LH) latest ratings and price target changes.

23/08/2019 Broker: Morgan Stanley Rating: Overweight Old Target: $190.0000 New Target: $201.0000 Maintain
08/08/2019 Broker: KeyBanc Capital Markets Rating: Overweight Old Target: $172.0000 New Target: $192.0000 Maintain
26/07/2019 Broker: Morgan Stanley Rating: Overweight Old Target: $175.0000 New Target: $190.0000 Maintain
16/07/2019 Broker: Bank of America Old Rating: Underperform New Rating: Neutral Upgrade
21/06/2019 Broker: Deutsche Bank Old Rating: Hold New Rating: Buy Old Target: $180.0000 New Target: $220.0000 Upgrade
30/05/2019 Broker: BidaskScore Rating: Buy Upgrade
03/05/2019 Broker: BidaskScore Rating: Buy Upgrade
02/05/2019 Broker: Canaccord Genuity Old Rating: Hold New Rating: Hold Old Target: $155.0000 New Target: $165.0000 Maintain
01/05/2019 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $157.0000 New Target: $176.0000 Maintain
01/05/2019 Broker: UBS Old Rating: Buy New Rating: Buy Old Target: $178.0000 New Target: $195.0000 Maintain

The stock decreased 0.29% or $0.5 during the last trading session, reaching $172.3. About 417,036 shares traded. Laboratory Corporation of America Holdings (NYSE:LH) has declined 2.94% since September 13, 2018 and is downtrending. It has underperformed by 2.94% the S&P500.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $16.83 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 20.33 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

More notable recent Laboratory Corporation of America Holdings (NYSE:LH) news were published by: Finance.Yahoo.com which released: “These 4 Measures Indicate That Laboratory of America Holdings (NYSE:LH) Is Using Debt Reasonably Well – Yahoo Finance” on September 02, 2019, also Businesswire.com with their article: “LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Interest – Business Wire” published on September 11, 2019, Businesswire.com published: “Covance Launches Laboratory Data Management Functional Service Provider for Pharmaceutical and Biotechnology Customers – Business Wire” on August 29, 2019. More interesting news about Laboratory Corporation of America Holdings (NYSE:LH) were released by: Seekingalpha.com and their article: “Stocks To Watch: Apple, IPOs And German Auto – Seeking Alpha” published on September 07, 2019 as well as Finance.Yahoo.com‘s news article titled: “If You Had Bought Laboratory of America Holdings (NYSE:LH) Shares Five Years Ago You’d Have Made 62% – Yahoo Finance” with publication date: June 05, 2019.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.